Related references
Note: Only part of the references are listed.Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases
Bianca Beghe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Phosphodiesterase 4-targeted treatments for autoimmune diseases
Neal Kumar et al.
BMC MEDICINE (2013)
Systemic methotrexate therapy for psoriasis: past, present and future
S. Dogra et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)
Novel small molecule therapeutics in rheumatoid arthritis
Victoria Kelly et al.
RHEUMATOLOGY (2013)
Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis
Chong Meng Yeo et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Effect of methotrexate on inflammatory cells redistribution in experimental adjuvant arthritis
Lucia Feketeova et al.
RHEUMATOLOGY INTERNATIONAL (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Interleukin-1β and Interleukin-6 in Arthritis Animal Models: Roles in the Early Phase of Transition from Acute to Chronic Inflammation and Relevance for Human Rheumatoid Arthritis
Gianfranco Ferraccioli et al.
MOLECULAR MEDICINE (2010)
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis
Fiona E. McCann et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
Sherine E. Gabriel et al.
ARTHRITIS RESEARCH & THERAPY (2009)
The role of physical activity in rheumatoid arthritis
Guy Plasqui
PHYSIOLOGY & BEHAVIOR (2008)
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis
M. Hegen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
J. A. M. Wessels et al.
RHEUMATOLOGY (2008)
Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma
Yang-mei Deng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Mechanisms of disease:: the molecular and cellular basis of joint destruction in rheumatoid arthritis
U Müller-Ladner et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2005)
Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevant to rheumatoid arthritis
JY Cho et al.
PHARMACOLOGICAL RESEARCH (2004)
Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis
JN Francischi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)